Stock Region Penny Picks
📈 Stock Region Watchlist Newsletter - Tuesday, August 12, 2025.
📈 Stock Region Watchlist Newsletter - Tuesday, August 12, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
⚠️ DISCLAIMER: This newsletter is for informational and educational purposes only. Nothing contained herein should be construed as investment advice. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Stock Region is not a registered investment advisor.
Hey Stock Region Family! 👋
What a day to be watching the markets! I'm practically buzzing with excitement over some of the moves we're seeing today. The CPI data came in right where we expected (well, mostly), and our watchlist is absolutely cooking with some jaw-dropping performances.
Let me dive right into what's got my attention today...
🔥 Today's Hot Movers
$TRIB - Trinity Biotech
+34% at $1.12 | Volume: 2.7M
Holy moly! This one caught fire after their breakthrough clinical trial results for their redesigned CGM sensor. When I see a biotech stock move like this on legitimate clinical news, it gets my heart racing. The volume is telling a story here - 2.7 million shares traded means real institutional interest, not just retail FOMO. This could have legs if the trial data holds up to scrutiny.
💰 Revenue Rockstars
$ZENA
This one's got me scratching my head in the best way possible. Over 500% year-over-year revenue growth for Q2? And over 250% for the first half of the year? I mean, come on - numbers like these make you do a double-take. Either they've cracked some serious code, or we're looking at a recovery story for the ages.
$ONDS - Ondas Holdings
Now THIS is what execution looks like! $6.3 million in quarterly revenue - that's a 6x increase year-over-year and 50% quarter-over-quarter. Plus they're sitting pretty with $68.6 million in cash. The autonomous drone space is heating up, and ONDS seems to be riding that wave perfectly.
$CYCU / IQST - IQSTEL
$35 million in July revenue alone? They've blown past their goals and are now running at a $400 million annual rate - five months ahead of schedule! Their path to $1 billion by 2027 suddenly doesn't look so crazy anymore.
🧬 Biotech & Pharma Updates
$XFOR - X4 Pharmaceuticals
Secured $60 million in equity financing with some management shuffling. Fresh money and new leadership can be exactly what a biotech needs to push through the next phase. I'm cautiously optimistic here.
$PRPH - ProPhase Labs
Full USPTO approval for their esophageal cancer risk assessment patent? In today's precision medicine world, that's potentially huge IP to own. Patents in the diagnostic space can be gold mines if commercialized properly.
$CGTX - Cognition Therapeutics
The FDA alignment on their Phase 3 Alzheimer's trial design is massive news. Alzheimer's treatments are notoriously difficult, but when the FDA gives you a clear path forward, that's worth paying attention to.
$GBIO - Generation Bio
New data on their delivery system and T-cell programs. The gene therapy space is exploding, and any company making real progress here deserves a spot on your radar.
📊 Market Pulse Check
Today's CPI data was mostly in line with expectations:
CPI m/m: 0.2% (as expected)
CPI y/y: 2.7% (slightly better than 2.8% expected)
Core CPI y/y: 3.1% (a touch higher than 3.0% expected)
The market seems to be taking this in stride. We're still in that sweet spot where inflation is cooling but not crashing.
💎 Wild Card Watch
$ATNF - 180 Life Sciences
They closed a $156 million convertible note offering and - get this - they're holding 82,186 ETH (worth about $228 million at current prices). A biotech company with a crypto treasury? Now that's not something you see every day. It's either genius diversification or a head-scratcher - jury's still out.
🎯 The Stock Region Take
Folks, days like today remind me why I love this game. We've got revenue explosions, breakthrough clinical data, smart capital raises, and even some crypto wildcards thrown in for good measure.
The biotech sector is particularly spicy right now - between TRIB's clinical breakthrough and the various pipeline advances from CGTX, PRPH, and GBIO, there's real innovation happening that could translate to serious returns.
But remember - with great opportunity comes great risk. These smaller caps can move fast in both directions, so size your positions accordingly and always have your exit strategy mapped out.
Stay sharp out there!
Happy Trading,
The Stock Region Team 📈
⚠️ FINAL DISCLAIMER: Past performance does not guarantee future results. All securities mentioned are for informational purposes only and should not be considered recommendations to buy or sell. The author may hold positions in securities mentioned. Market data and prices are subject to change. Please invest responsibly and never risk more than you can afford to lose.
Want more insights like this? Subscribe to us for daily market updates and watchlist alerts!